KJ Muldoon, a 10-month-old baby, was diagnosed with the genetic disease carbamoyl-phosphate synthetase 1 deficiency after he ...

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...

Sanofi's rilzabrutinib earns its fourth orphan drug status from the FDA, this time targeting sickle cell disease.

Nagpur: AIIMS Nagpur is set to establish a Bone Marrow Transplant (BMT) centre with significant funding from NTPC under its ...

The CEO of the African Medical Centre of Excellence (AMCE), Brian Deaver, has disclosed that the Ford Foundation has ...

An algorithm is helping to reduce the number of unnecessary hospital admissions for children with sickle cell.

Chairperson of Qatar Foundation for Education, Science and Community Development, Her Highness Sheikha Moza bint Na ...

Columnist Oluwatosin Adesoye explains why preventing malaria infections is particularly important for those with sickle cell ...

Beam Therapeutics (NASDAQ:BEAM) gains FDA orphan drug status for BEAM-101 to treat sickle cell disease. Read more here.